Portfolio

Our diverse portfolio includes disruptive ventures with disruptive solutions that fundamentally drive transformation and deliver value across the industry.

Exits

Acquired by Johnson & Johnson | 2024
Acquired by Medtronic | 2023
Acquired by Tivity Health | 2023
Acquired by Accolade | 2021
Acquired by 1-800 Contacts | 2019
Acquired by Stryker | 2019
Acquired by Palo Alto Networks | 2019
Acquired by TransEnterix | 2018
Acquired by Thoratec | 2014